Example: Heart Attack
Search clinical trials for: Bunazosin
Total 1 results
-
NCT00130156CompletedConditions: High Blood Pressure
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Breakthrough Seizures
- Cognitive Decline
- Countermovement Jump
- Eosinophilic Gastrointestinal Disorders
- Germ Cell Tumour
- Histiocytic Sarcoma
- Major Salivary Gland Carcinoma
- Mastoidectomy
- Neoplasm, Advanced or Metastatic
- Patient Adherence, Chronic Hepatitis C, Alcohol-related Disorders
- Post-operative Tooth Pain
- Stage IV (Metastatic) Breast Cancer
- Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7
- View Full List
Sponsors and Collaborators
- ArthroCare Corporation
- British Eye Research Foundation, operating as Fight for Sight
- Cernelle, Ängelholm, Sweden
- EFOR
- Ethiopian Society of Obstetricians and Gynecologists
- Fakkel bvba
- Intech Biopharm Ltd.
- Kheth'Impilo
- Lisa Wood
- LuMind Research Down Syndrome Foundation
- Mark H. Einstein
- Reconstrata, LLC
- ResMed
- View Full List
Drug Interventions
- Amoxicillin 500 mg tid
- Colchicine vs Placebo
- FOLFOX (oxaliplatin, leucovorin, 5-fluorouracil [5FU])
- Halobetasol Proprionate Lotion 0.05%
- IBI302 (the first dose level)
- Lu-177-DOTA-girentuximab
- MK0476, Montelukast Sodium /Duration of Treatment : 14 Days
- Multi-ingredient, topical compounded medications
- Pegasys®
- Placebo (for UFH)
- crestor(Rosuvastatin)
- metronidazole and azithromycin
- oral masitinib
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations